Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radiofrequency Ablation for Liver Tumors

By HospiMedica staff writers
Posted on 17 Sep 2002
Using radiofrequency ablation (RFA) to destroy liver tumors is a promising alternative for patients who cannot endure surgery but require immediate removal of tumors.

The procedure can be done quickly, with little pain and minimal recovery time, and as often as needed, according to Rendon Nelson, M.D., a radiologist at Duke University (Durham, NC, USA; www.mc.duke.edu) who has performed more than 100 such procedures on tumors in the liver, kidneys, and bones since May 1999.

Ultrasound and computed tomography (CT) are used to guide a small probe through a quarter-inch incision in the skin and directly to the tumor site. More...
This probe is connected to an electronic device that delivers radiofrequency energy from the tip of several slender needles protruding from the probe. The procedure takes only an hour or two, followed by four to six hours of resting in a recovery room. After that, the patient, needing only a small bandage, can drive home.

"The procedure is better tolerated than surgery, there is no large abdominal wound to heal, and we can do the procedure as often as necessary,” said Dr. Nelson. "And the survival rate may end up being the same as with surgery, although it is too soon to tell yet.”




Related Links:
Duke University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.